HTLV-I seroprevalence in the Sultanate of Oman.
2329 subjects (blood donors and patients) from various areas of the Sultanate of Oman were investigated for the presence of HTLV-I antibody by as enzyme immunoassay (EIA) method. 10 subjects (0.4%), including 9/1586 blood donors (0.6%) and 1/165 patients with sexually transmitted diseases (0.6%), were found to be EIA seropositive with a regional variation in seroprevalence of 0-14%. 6/9 EIA seropositive samples from blood donors yielded 'indeterminate' results on Western immunoblot analysis (WBA). A much larger survey with additional confirmatory assays such as a radioimmunoprecipitation assay (RIPA), should provide a more conclusive picture of the prevalence of this retroviral infection in the Sultanate.
Knox-Macaulay
H
H
Department of Haematology, Sultan Qaboos University Hospital, Muscat, Oman.
McDonald
R
R
al-Busaidy
S
S
Ali
N
N
D001782:Blood Donors; D015153:Blotting, Western; D005260:Female; D005312:Fetal Blood / Q000276:immunology; D015481:HTLV-I Antibodies / Q000097:blood*; D015490:HTLV-I Infections / Q000453:epidemiology*; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D009850:Oman / Q000453:epidemiology; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000453:epidemiology; D016036:Seroepidemiologic Studies; D012749:Sexually Transmitted Diseases / Q000150:complications
D015481:HTLV-I Antibodies